Publications by authors named "David Corredor-Rengifo"

Claim this Profile
C
Correction: A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists - a comprehensive review.
David Aristizábal-Colorado, David Corredor-Rengifo, Santiago Sierra-Castillo, Carolina López-Corredor, David-Alexander Vernaza-Trujillo

Front Endocrinol (Lausanne)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists - a comprehensive review.
David Aristizábal-Colorado, David Corredor-Rengifo, Santiago Sierra-Castillo, Carolina López-Corredor, David-Alexander Vernaza-Trujillo

Front Endocrinol (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".
David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez, David Corredor-Rengifo, Jorge Rico-Fontalvo

Am J Cardiovasc Drugs· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of SGLT2 Inhibitors on Preventing Heart Failure Hospitalizations in Colombian Patients With Uncontrolled Type 2 Diabetes Mellitus.
David Alexander Vernaza Trujillo, Lendy Yaneth Rojas Bautista, Claudia Marcela Ramirez Espinosa, Santiago Sierra Castillo, David Corredor-Rengifo

Cureus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical Control in a Colombian Cohort of Patients With Acromegaly: A 12-Month Follow-Up Study (2017-2023).
Alin Abreu Lomba, David Corredor-Rengifo, Cesar Augusto Mejia Velez, Reynaldo Carvajal Ortiz, Doly Pantoja Guerrero

Cureus· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art.
David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez, David Corredor-Rengifo, Jorge Rico-Fontalvo

Am J Cardiovasc Drugs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacillus clausii Bacteremia Following Probiotic Use: A Report of Two Cases.
David Corredor-Rengifo, Maria E Tello-Cajiao, Fredy A García-Molina, Leonardo F Montero-Riascos, Janier D Segura-Cheng

Cureus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis